Corrigendum to “Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)” [Gynecol. Oncol. Rep. 31 (2020) 100532]

• Alessandro D. Santin,
• Virginia Filiaci,
• Stefania Bellone,
• Roisin O'Cearbhaill,
• Elena S. Ratner,
• Cara A. Mathews,
• Guilherme Cantuaria,
• Camille C. Gunderson,
• Teresa Rutledge,
• Barbara M. Buttin,
• Heather A. Lankes,
• Michael J. Birrer

Affiliations

Alessandro D. Santin

Department of Obstetrics, Gynecology & Reproductive Services, Yale University School of Medicine, New Haven, CT 06520, USA; Corresponding author at: Yale University School of Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, Room 305 LSOG, 333 Cedar Street, P.O. Box 208063, New Haven, CT 06520-8063, USA.

Virginia Filiaci

NRG Oncology Statistical and Data Management Center, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA

Stefania Bellone

Department of Obstetrics, Gynecology & Reproductive Services, Yale University School of Medicine, New Haven, CT 06520, USA

Roisin O'Cearbhaill

Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA

Elena S. Ratner

Department of Obstetrics, Gynecology & Reproductive Services, Yale University School of Medicine, New Haven, CT 06520, USA

Cara A. Mathews

Medical Oncology, Women & Infants Hospital, 101 Dudley Street, Providence, RI 02905, USA

Guilherme Cantuaria

Gynecologic Oncology, 980 Johnson Ferry Road #910, Atlanta, GA 30342, USA

Camille C. Gunderson

Department of Obstetrics & Gynecology, University of Oklahoma, The Stephenson Cancer Center, 800 NE 10th Street, Suite 2500, Oklahoma City, OK 73104, USA

Teresa Rutledge

Gynecologic Oncology, University of New Mexico, 1201 Camino de Salud, Albuquerque, NM 87102, USA

Barbara M. Buttin

Department of Obstetrics & Gynecology, Northwestern Medicine Regional Medical Group, 4405 Weaver Parkway, Warrenville, IL 60555-3269, USA

Heather A. Lankes

NRG Oncology, Operations Center-Philadelphia East, Philadelphia, PA, USA; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, USA

Michael J. Birrer

Division of Hematology/Oncology, O’Neal Cancer Center University of Alabama, 176F 10390, 619 19th Street S, Birmingham, AL, USA